Investors & Media

Corporate Profile

Investor Relations

Corporate Profile


Sage Therapeutics (Nasdaq: SAGE) is a biopharmaceutical company committed to our mission of pioneering solutions to deliver life-changing brain health medicines, so every person can thrive. Sage developed the only two FDA-approved treatments indicated for postpartum depression and is advancing a robust pipeline to target unmet needs in brain health. Sage was founded in 2010 and is headquartered in Cambridge, Mass. Engage with us on FacebookLinkedInInstagram, and X.


Investor Inquiries:
Media Inquiries:

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Sage Therapeutics Intra Stock Chart